on March 10, 2025 at 1:56 pm Novo Nordisk Shares Fall After Latest CagriSema Obesity Drug Trial Results​Dominic Chopping

New trial data showed the drug helped obese or overweight type 2 diabetics lose an average 15.7% of their weight, when an earlier study recorded 22.7%.